Association between DAPK1 promoter methylation and cervical cancer: A meta-analysis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Xiong, Jiaqiang ^a   Li, Ya ^a   Huang, Kecheng ^a   Lu, Meixia ^a   Shi, Hao ^a   Ma, Lanfang ^a   Luo, Aiyue ^a   Yang, Shuhong ^a   Lu, Zhiyong ^a   Zhang, Jinjin ^a   Yang, Lilan ^b   Wang, Shixuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; DAPK1 PROTEIN, HUMAN;

ARTICLE; CANCER TISSUE; CARCINOGENESIS; DAPK1 GENE; DISEASE MARKER; DNA METHYLATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MOLECULAR PATHOLOGY; PROMOTER REGION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; UTERINE CERVIX TUMOR;

DEATH-ASSOCIATED PROTEIN KINASES; DNA METHYLATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROMOTER REGIONS, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 84907564361     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107272     Document Type: Article

References (28)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Schiffman MH, Castle P (2003) Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 95: E2.
3. Flatley JE, McNeir K, Balasubramani L, Tidy J, Stuart EL, et al. (2009) Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis. Cancer Epidemiol Biomarkers Prev 18: 2782-2789.
4. Hesson LB, Cooper WN, Latif F (2007) The role of RASSF1A methylation in cancer. Dis Markers 23: 73-87.
5. Barton CA, Hacker NF, Clark SJ, O'Brien PM (2008) DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment. Gynecol Oncol 109: 129-139.
6. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, et al. (2001) Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10: 687-692.
7. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
8. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
9. Stuck AE, Rubenstein LZ, Wieland D (1998) Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ 316: 469; author reply 470-461.
10. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
11. Dong SM, Kim HS, Rha SH, Sidransky D (2001) Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7: 1982-1986.
12. Feng Q, Hawes SE, Stern JE, Dem A, Sow PS, et al. (2007) Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia. Cancer Epidemiol Biomarkers Prev 16: 1178-1184.
13. Iliopoulos D, Oikonomou P, Messinis I, Tsezou A (2009) Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression. Oncol Rep 22: 199-204.
14. Jeong DH, Youm MY, Kim YN, Lee KB, Sung MS, et al. (2006) Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics. Int J Gynecol Cancer 16: 1234-1240.
15. Kang S, Kim JW, Kang GH, Park NH, Song YS, et al. (2005) Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 96: 173-180.
16. Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, et al. (2010) Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Gynecol Oncol 116: 99-104.
17. Leung RC, Liu SS, Chan KY, Tam KF, Chan KL, et al. (2008) Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer. Oncol Rep 19: 1339-1345.
18. Missaoui N, Hmissa S, Trabelsi A, Traore C, Mokni M, et al. (2011) Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix. Pathol Res Pract 207: 37-42.
19. Niyazi M, Liu XW, Zhu KC (2012) [Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women]. Zhonghua Zhong Liu Za Zhi 34: 31-34.
20. Shivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS, et al. (2007) Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol Oncol 107: 549-553.
21. Sun LL, Cao DY, Yang JX, Li H, Zhou XR, et al. (2012) Population-based casecontrol study on DAPK1, RAR-beta2 and MGMT methylation in liquid-based cytology. Arch Gynecol Obstet 285: 1433-1439.
22. Yang N, Nijhuis ER, Volders HH, Eijsink JJ, Lendvai A, et al. (2010) Gene promoter methylation patterns throughout the process of cervical carcinogenesis. Cell Oncol 32: 131-143.
23. Zhao XL, Meng ZY, Qiao YH, Zhang HL (2008) [Promoter methylation of DAPK gene in cervical carcinoma]. Ai Zheng 27: 919-923.
24. Reesink-Peters N, Wisman GB, Jeronimo C, Tokumaru CY, Cohen Y, et al. (2004) Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res 2: 289-295.
25. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, et al. (1997) DAP kinase links the control of apoptosis to metastasis. Nature 390: 180-184.
26. Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, et al. (2006) Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol 24: 4262-4269.
27. Hiraga J, Kinoshita T, Ohno T, Mori N, Ohashi H, et al. (2006) Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma. Int J Hematol 84: 248-255.
28. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, et al. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: E32.